HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol

HCID 25224976
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
866607-35-4
Standard SMILES
CC(=O)OC[C@H]1O[C@@H](c2ccc(C)c(Cc3ccc(-c4ccc(F)cc4)s3)c2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
InChIKey
XYBGJUIUCFENGS-IFUGWHCZSA-N
Molecular formula
C32H33FO9S
Average molar mass
612.7 g/mol
Monoisotopic mass
612.18293196

Names & identifiers

Preferred name
(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol
IUPAC
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]oxan-2-yl]methyl acetate
English name
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI)
Molecular formula
C32H33FO9S
Molecular weight
612.66

Names & synonyms

EC 617-901-5(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol(1S)-2,3,4,6-TETRA-O-ACETYL-1,5-ANHYDRO-1-(3-{[5-(4-FLUOROPHENYL)THIOPHEN-2-YL]METHYL}-4-METHYLPHENYL)-D-GLUCITOLRefChem:393852617-901-5866607-35-4(2R,3R,4R,5S,6S)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetateCanagliflozin TetraacetateCanagliflozin Impurity 88SCHEMBL3403203[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]oxan-2-yl]methyl acetateD-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI)
Show more names
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol tetraacetateCanagliflozin-2Canagliflozin TetraD-glucitol tetraacetateCagliflozin Impurity 12canagliflozin impurities8Tetra Acetyl Canagliflozincanagliflozin impurities621(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)...
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetraacetateC32H33FO9SMFCD28167873DTXSID501045094UBS5P45257CS-M2420EX-A2757AKOS030528591

Database identifiers

CAS
866607-35-4
PubChem CID
25224976
DTXSID
DTXSID501045094
UNII
UBS5P45257
EC Number
617-901-5
Nikkaji
J2.839.624D

Properties

Computed structural propertiesFilling in

XLogP
5
Topological polar surface area
143 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
11
Rotatable bonds
13
Heavy atoms
43
Formal charge
0
Complexity
986

Physicochemical properties

Melting point
160 · 160-170 °C
Boiling point
658.3 · 658.3±55.0 °C(Predicted)
Density
1.32 · 1.32±0.1 g/cm3(Predicted)
vapor pressure
0 Pa · 0Pa at 20℃
storage temp.
2 · Storage temp. 2-8°C
solubility
soluble in Chloroform, Ethyl Acetate, Methanol
form
Solid
color
White
LogP
5.5 at · 5.5 at 20℃
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P280-P301+P312-P302+P352-P305+P351+P338
REACH Registrations
Inactive

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Regulatory InformationREACH registered substance: (1S)-2,3,4,6-TETRA-O-ACETYL-1,5-ANHYDRO-1-(3-{[5-(4-FLUOROPHENYL)THIOPHEN-2-YL]METHYL}-4-METHYLPHENYL)-D-GLUCITOL (EC: 617-901-5)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
REACH Registrations
Inactive
Precautionary statements
P261-P280-P301+P312-P302+P352-P305+P351+P338

Chemistry & industry

Applications · 1 item

UsesThe title compound is an intermediate in the synthesis of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.

Related reactions

1 records
New reaction record
HRID 2172701 reaction equation
HRID 2172701As reactant

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes